COPD Study

This study is testing a drug called tezepelumab to see if it could be an effective and safe treatment for patients with COPD.

Tezepelumab may help decrease inflammation in the lungs of people with COPD, which could reduce episodes of worsening of COPD symptoms (called flare-ups), and improve lung function, health-related quality of life, and overall health.

All patients will continue to take their regular COPD medication throughout the study. You will be assigned to add either the study drug or “placebo” to your regular medication.

The study drug will be administered by two injections under your skin (sub-cutaneous) every 4 weeks for up to 72 weeks, and the “placebo” will be injections that does not contain any study medicine.